Abstract
Basal cell carcinoma (BCC) is a malignant cutaneous neoplasm capable of extensive tissue destruction. It is often observed on the head and neck, and the eyelids are a common location. BCC was initially described as a distinct entity by Krompecher [1] at the beginning of the twentieth century. Some authorities preferred the term “epithelioma” to carcinoma because of the tumor’s limited capacity to metastasize [1]. While the mortality from BCC is low, the morbidity may be considerable.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol. 1993;38:169–92.
Allali J, D’Hermies F, Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica. 2005;219:57–71.
Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs Database, Part I: periocular basal cell carcinoma. Experience over 7 years. Ophthalmology. 2004;111:624–30.
Paavilainen V, Tuominen J, Pukkala E, Saari KM. Basal cell carcinoma of the eyelid in Finland during 1953–97. Acta Ophthalmol Scand. 2005;83:215–20.
Lim VSY, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96:1462–5.
Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol. 1978;4:23–8.
Bakis S, Irwig L, Wood G, Wong D. Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis. Br J Dermatol. 2004;150:829–36.
Leibovitch I, McNab A, Sulivan T, et al. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112:717–23.
Allan E, Pye DA, Levine EL, Moore JV. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy. Lasers Med Sci. 2002;17:230–7.
Nori S, Rius-Diaz F, Cuevas J, et al. Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol. 2004;51:923–30.
Murra DE, Torres A, Schanbacher CF, Gonzales S. Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol Surg. 2005;31:538–41.
Cook Jr BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108:2088–98.
Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs Database, Part II. Periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology. 2004;111:631–6.
Morris DS, Elzaridi E, Clarke L, Dickinson AJ, Lawrence CM. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br J Ophthalmol. 2009;93(4):474–6.
Lindgren G, Larko O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol. 1997;36:742–6.
Tuppurainen K. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graefes Arch Clin Exp Ophthalmol. 1995;233:205–8.
Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003;29:566–71.
Jaramillo-Averbe F. Cryosurgery in difficult to treat basal cell carcinoma. Int J Dermatol. 2000;39:223–9.
Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76:100–6.
Jefford M, Kiffer JD, Somers G, et al. Metastatic cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004;74:704–5.
Wang I, Bauer B, Andersson-Engels S, et al. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand. 1999;77:182–8.
Ingves C, Jemec GBE. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma. Scand J Plast Reconstr Surg Hand Surg. 2003;37:293–5.
Rhodes LE, de Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17–23.
Garcia-Martin E, Gil-Arribas LM, Idoipe M, Alfaro J, Pueyo V, Pablo LE, Fernandez FJ. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol. 2011;95:1393–6.
Sekulic A, Migden M, Oro A, Dirix L. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171–9.
Curson C, Weedon D. Spontaneous regression in basal cell carcinoma. J Cutan Pathol. 1979;6:432–7.
Edge SE, Byrd DR, Carducci MA, Compton CA, editors. Carcinoma of the eyelid. In: AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Crawford C, Fernelius C, Young P, Groo S, Ainbinder D. Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol. 2011;5:1645–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rosner, M., Fabian, I.D. (2014). Basal Cell Carcinoma. In: Pe'er, J., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38336-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-38336-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38335-9
Online ISBN: 978-3-642-38336-6
eBook Packages: MedicineMedicine (R0)